Cyclosporine ophthalmic Alternatives Compared
| Cyclosporine ophthalmic | Restasis (cyclosporine) | Cequa (cyclosporine) |
|
|---|
| Cyclosporine ophthalmic | Restasis (cyclosporine) | Cequa (cyclosporine) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Dry Eye Disease, Keratoconjunctivitis. Cyclosporine ophthalmic may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Dry Eye Disease. Restasis may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Dry Eye Disease. Cequa may also be used for purposes not listed in this medication guide. |
Related suggestions Dry Eye Disease (Keratoconjunctivitis Sicca)
Popular comparisons
|
|||||||||||||||||||||||
| More about Cyclosporine ophthalmic | More about Restasis (cyclosporine) | More about Cequa (cyclosporine) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Cyclosporine ophthalmic has an average rating of 4.7 out of 10 from a total of 287 ratings on Drugs.com. 27% of reviewers reported a positive effect, while 46% reported a negative effect. |
Restasis has an average rating of 4.6 out of 10 from a total of 224 ratings on Drugs.com. 26% of reviewers reported a positive effect, while 47% reported a negative effect. |
Cequa has an average rating of 4.8 out of 10 from a total of 39 ratings on Drugs.com. 31% of reviewers reported a positive effect, while 44% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
View all Cyclosporine ophthalmic side effects |
View all Restasis side effects |
View all Cequa side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
||||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Cyclosporine ophthalmic prices |
View all Restasis prices |
View all Cequa prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Cequa, Restasis, Verkazia, Vevye | Other cyclosporine brands include: Cequa, Verkazia, Vevye | Other cyclosporine brands include: Restasis, Verkazia, Vevye | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 15 drugs are known to interact with Cyclosporine ophthalmic:
|
A total of 15 drugs are known to interact with Restasis:
|
A total of 15 drugs are known to interact with Cequa:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
December 23, 2002 |
December 23, 2002 |
August 14, 2018 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Chantix
Chantix is a smoking cessation medicine used with behavior modification and counseling to help you ...
Restasis
Restasis is used to treat chronic dry eye that may be caused by inflammation. Learn about side ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Xiidra
Xiidra (lifitegrast 5%) is an eye drop solution that is used twice daily in each eye to treat the ...
Miebo
Miebo (perfluorohexyloctane) is used to treat the signs and symptoms of dry eye disease. Includes ...
Maxitrol
Maxitrol is used for blepharitis, conjunctivitis, bacterial, keratitis, keratoconjunctivitis, uveitis
Cequa
Cequa (cyclosporine ophthalmic) is a prescription eye drop used to treat chronic dry eye from ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.